There’s nothing quite like knowing someone all their life to create a bond strong enough to see you through the toughest of times. Just ask CBR (Cells for Life’s sister company) parents Whitney and Ely.* Good friends since elementary school, they began dating while...
What if treating extremely preterm babies with their own (i.e., autologous) cord blood stem cells could reduce their increased risk of brain damage and related conditions? Using a patient’s own cord blood stem cells to treat neurological conditions, like cerebral...
Eliza Stroh, MS, CGC, Cord Blood Clinical Specialist This July, Cells for Life highlights the triumphs of newborn stem cell science as we continue to spread the word about the valuable resource of cord blood and cord tissue preservation. Here, we review the unique...
Join us this July as we celebrate Cord Blood Awareness Month, a time to shine a light on the remarkable healing potential of newborn stem cells. At Cells for Life, we are dedicating this entire month to educating parents about the importance of newborn stem cell...
The FDA made history in April with its first-ever approval of an expanded cord blood product for use as a primary treatment in hematopoietic stem cell transplants (HSCT) for certain blood cancers in adults and children 12 years of age and older.1 Why is cord...
November is World Prematurity Month, which is dedicated to raising awareness of preterm birth. Preterm birth is the delivery of a baby prior to 37 weeks gestation – or more than 3 weeks prior to the due date. Staying pregnant to full term is one of the best ways to...
